BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10890474)

  • 1. Hirudin monitoring using the TAS ecarin clotting time in patients with heparin-induced thrombocytopenia type II.
    Koster A; Hansen R; Grauhan O; Hausmann H; Bauer M; Hetzer R; Kuppe H; Mertzlufft F
    J Cardiothorac Vasc Anesth; 2000 Jun; 14(3):249-52. PubMed ID: 10890474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant hirudin as an alternative for anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II: a 1-year experience in 57 patients.
    Koster A; Hansen R; Kuppe H; Hetzer R; Crystal GJ; Mertzlufft F
    J Cardiothorac Vasc Anesth; 2000 Jun; 14(3):243-8. PubMed ID: 10890473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring of r-hirudin anticoagulation during cardiopulmonary bypass--assessment of the whole blood ecarin clotting time.
    Pötzsch B; Madlener K; Seelig C; Riess CF; Greinacher A; Müller-Berghaus G
    Thromb Haemost; 1997 May; 77(5):920-5. PubMed ID: 9184403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified plasma-based ecarin clotting time assay for monitoring of recombinant hirudin during cardiac surgery.
    Choi TS; Khan AI; Greilich PE; Kroll MH
    Am J Clin Pathol; 2006 Feb; 125(2):290-5. PubMed ID: 16393689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quick assay for monitoring recombinant hirudin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II : adaptation of the ecarin clotting time to the act II device.
    Koster A; Loebe M; Hansen R; Bauer M; Mertzlufft F; Kuppe H; Hetzer R
    J Thorac Cardiovasc Surg; 2000 Jun; 119(6):1278-83. PubMed ID: 10838548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rotational thrombelastometry for the bedside monitoring of recombinant hirudin.
    Sucker C; Zotz RB; Görlinger K; Hartmann M
    Acta Anaesthesiol Scand; 2008 Mar; 52(3):358-62. PubMed ID: 18205897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between hirudin and activated clotting time: implications for patients with heparin-induced thrombocytopenia undergoing cardiac surgery.
    Despotis GJ; Hogue CW; Saleem R; Bigham M; Skubas N; Apostolidou I; Qayum A; Joist JH
    Anesth Analg; 2001 Jul; 93(1):28-32. PubMed ID: 11429333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulation with r-hirudin in regular haemodialysis with heparin-induced thrombocytopenia (HIT II). The first long-term application of r-hirudin in a haemodialysis patient.
    Nowak G; Bucha E; Brauns I; Czerwinski R
    Wien Klin Wochenschr; 1997 May; 109(10):354-8. PubMed ID: 9200807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
    Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of ecarin clotting time in whole blood for monitoring recombinant hirudine treatment during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia].
    Devignes J; de Maistre E; Grosjean S; Walter AF; Hacquard M; Mulot A; Longrois D; Carteaux JP; Lecompte T
    Ann Biol Clin (Paris); 2005; 63(2):201-8. PubMed ID: 15771978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant hirudin anticoagulation for aortic valve replacement in heparin-induced thrombocytopenia.
    Longrois D; de Maistre E; Bischoff N; Dopff C; Meistelman C; Angioï M; Lecompte T
    Can J Anaesth; 2000 Mar; 47(3):255-60. PubMed ID: 10730738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of recombinant hirudin: assessment of a plasma-based ecarin clotting time assay.
    Pötzsch B; Hund S; Madlener K; Unkrig C; Müller-Berghaus G
    Thromb Res; 1997 Jun; 86(5):373-83. PubMed ID: 9211628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lepirudin during cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia].
    Boinot C; Lanquetot H; Macchi L; Charrière JM; Menu P
    Ann Fr Anesth Reanim; 2003 Jul; 22(7):635-8. PubMed ID: 12946496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful use of recombinant hirudin and its monitoring by ecarin clotting time in patients with heparin-induced thrombocytopenia undergoing off-pump coronary artery revascularization.
    Iqbal O; Tobu M; Aziz S; Gerdisch M; Da Valle M; Demir M; Hoppensteadt DA; Ahmad S; Walenga JM; Fareed J
    J Card Surg; 2005; 20(1):42-51. PubMed ID: 15673409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring of hirudin therapy with the Thrombelastograph.
    Pivalizza EG
    J Clin Anesth; 2002 Sep; 14(6):456-8. PubMed ID: 12393117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac surgery in patients with heparin-induced thrombocytopenia using preoperatively determined dosages of iloprost.
    Antoniou T; Kapetanakis EI; Theodoraki K; Rellia P; Thanopoulos A; Kotiou M; Zarkalis D; Alivizatos P
    Heart Surg Forum; 2002; 5(4):354-7. PubMed ID: 12538117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elimination of recombinant hirudin by modified ultrafiltration during simulated cardiopulmonary bypass: assessment of different filter systems.
    Koster A; Merkle F; Hansen R; Loebe M; Kuppe H; Hetzer R; Crystal GJ; Mertzlufft F
    Anesth Analg; 2000 Aug; 91(2):265-9. PubMed ID: 10910829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of heparin resistance during cardiopulmonary bypass: the effect of five different anticoagulation strategies on hemostatic activation.
    Koster A; Fischer T; Gruendel M; Mappes A; Kuebler WM; Bauer M; Kuppe H
    J Cardiothorac Vasc Anesth; 2003 Apr; 17(2):171-5. PubMed ID: 12698397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of ecarin clotting time (ECT) with lepirudin therapy in heparin-induced thrombocytopenia and cardiopulmonary bypass.
    Fabrizio MC
    J Extra Corpor Technol; 2001 May; 33(2):117-25. PubMed ID: 11467439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of ecarin chromogenic assay and prothrombinase induced clotting time in the monitoring of lepirudin for the treatment of heparin-induced thrombocytopenia.
    Guy S; Kitchen S; Laidlaw S; Cooper P; Woolley A; Maclean R
    Br J Haematol; 2008 Jul; 142(3):466-8. PubMed ID: 18510685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.